3006343
print

Prenatal Hepatitis Panel

PRENAT HEP
Example Reports
High Positive
Low Positive
Negative

Ordering Recommendation

Use for hepatitis B virus (HBV) and hepatitis C virus (HCV) prenatal screening. If initial result is positive for HCV, test reflexes to quantitative nucleic acid amplification to confirm HCV infection.

Methodology

Qualitative Chemiluminescent Immunoassay (CLIA)/Quantitative Transcription-Mediated Amplification (TMA)

Performed

Sun-Sat

Reported

1-4 days
Within 24 hours. If reflexed, add 1-3 days.

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation
Collect

Serum separator tube (SST). Also acceptable: Pink (K2EDTA) and Lavender (EDTA).

Specimen Preparation

Separate from cells ASAP or within 2 hours of collection. Transfer 3 mL serum or plasma to an ARUP standard transport tube. (Min: 2.0 mL)

Storage/Transport Temperature

Frozen

Unacceptable Conditions

Specimen: Body fluids other than serum or plasma.
Condition: Heparinized plasma. Specimens containing particulate material or obvious microbial contamination. Heat-inactivated, severely hemolyzed or lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 2 months (avoid freeze/thaw cycles)

Reference Interval

Test Number
 Components
 Reference Interval
  Hepatitis C Antibody by CIA Interp Negative
  Hepatitis B Surface Antigen, Prenatal Negative

Interpretive Data

This test should not be used for blood donor screening, associated reentry protocols, or for screening human cells, tissues, and cellular- and tissue-based products (HCT/P).


Components Interpretation
Hepatitis C Antibody by CIA Index 0.79 IV or less Negative
0.80 to 0.99 IV Equivocal
1.00 to 10.99 IV Low Positive
11.00 IV or greater High Positive

Compliance Category

FDA

Note

Order this test only for prenatal specimens. If results for HBsAg screen are reactive (≥ 1.0), then HBsAg Confirmation, Prenatal will be added. Additional charges apply.

If the anti-HCV screening result is low positive or high positive, the Hepatitis C Virus by Quantitative NAAT will be added. Additional charges apply.

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
05/15/2023
X
N/A

CPT Codes

87340; 86803; if reflexed, add 87341; 87522

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
0020099 Hepatitis C Antibody by CIA Interp 13955-0
2002404 Hepatitis C Antibody by CIA Index 57006-9
2007574 Hepatitis B Surface Antigen, Prenatal 48767-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Anti-HCV
  • HCV Ab
  • HCV Antibody
  • HCVAB, Serum
  • Hepatitis B surface antigen, prenatal
  • Hepatitis C Viral Antibody, Serum
  • Hepatitis C Virus (HCV) Antibody With Reflex to Quantitative Real-time PCR, prenatal
  • non-A, non-B Hepatitis
  • Prenatal HBsAg confirmation
  • Prenatal hepatitis C Antibody with Reflex to HCV RNA Quantitative Real-Time PCR
  • Prenatal hepatitis C Antibody with Reflex to Hepatitis C Virus RNA Quantitative Real-Time PCR
  • Prenatal Reflexive Panel
Prenatal Hepatitis Panel